imazodan has been researched along with zardaverine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Dhar, S; Fryknäs, M; Gullbo, J; Gustafsson, MG; Isaksson, A; Larsson, R; Lövborg, H; Nygren, P; Rickardson, L; Wickström, M | 1 |
2 other study(ies) available for imazodan and zardaverine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.
Topics: Carcinoma, Squamous Cell; Caspases; Combinatorial Chemistry Techniques; Drug Evaluation, Preclinical; Electronic Data Processing; Gene Expression Profiling; HeLa Cells; Humans; Models, Biological; Oligonucleotide Array Sequence Analysis; Phenotype; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridazines; Quinazolines; RNA, Messenger; Signal Transduction | 2006 |